8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed May 20, 2026 · 1mo ago · Accession 0001193125-26-232524
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- INOVIO PHARMACEUTICALS, INC.
- Ticker
- INO
- CIK
- 1055726
- Form type
- 8-K
- Filing date
- May 20, 2026
- Report date
- May 19, 2026
- Document
- d138309d8k.htm
- Size
- 171 KB